September 8, 2024 S&P 500 In Freefall: Is This The End Of The Bull Market?
September 6, 2024 Jobs Report Spotlight As Fed Weighs Rate Cut Decision
August 26, 2024 NVDA Earnings Report Insights
August 22, 2024 Massive U.S. Job Growth Revision Shakes Economy And Markets
Amazon: Loading Up On This No-Brainer Buy Now
Apple: Not Surprising That Berkshire Sold Half
Wall Street Brunch: ‘It’s Glowtime’ For Apple
Nvidia: The Blackwell Delay And Its Consequences
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Altamira Therapeutics (CYTO) stock forecast for 2024
Updated: September 9, 2024 (19:07)
Sector: HealthcareThe share price of Altamira Therapeutics Ltd. (CYTO) now
50/200 Day Moving Average: $1.08 / $2.156
This figure corresponds to the Average Price over the previous 50/200 days. For Altamira Therapeutics stocks, the 50-day moving average is the resistance level today.
For Altamira Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Altamira Therapeutics Ltd. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Altamira Therapeutics stock price in 2024. How much will one Altamira Therapeutics share be worth in 2024? Is it worth taking profit / loss on CYTO stock now or waiting? What are analysts' forecasts for Altamira Therapeutics stock?
We forecast Altamira Therapeutics stock performance using neural networks based on historical data on CYTO stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Altamira Therapeutics Ltd. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Altamira Therapeutics analysts is $8.25. Today 200 Day Moving Average is the resistance level (2.156 $). 50 Day Moving Average is the resistance level (1.08 $).
Historical and forecast chart of Altamira Therapeutics Ltd. stock
The chart below shows the historical price of Altamira Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the CYTO stock price can be found in the table below.
Altamira Therapeutics Ltd is committed to the development of therapeutic agents to address unmet medical needs. It is active in the treatment of RNA, allergies and viral infections, as well as in diseases of the inner ear. Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.
Altamira Therapeutics (CYTO) Forecast for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct | 0.91 | 0.79 | 0.99 | 19.49 % |
| Nov | 0.90 | 0.86 | 0.95 | 9.11 % |
| Dec | 0.94 | 0.90 | 1.09 | 17.41 % |
Altamira Therapeutics information and performance
CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM 11, BM
Market capitalization of the Altamira Therapeutics Ltd. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CYTO shares in the company outstanding by the market price of one share.
EBITDA of Altamira Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Altamira Therapeutics price target for 2024 by month
Target values for the price of one Altamira Therapeutics share for Oct 2024.
In Oct, the Positive dynamics for Altamira Therapeutics Ltd. shares will prevail with possible monthly volatility of 19.485% volatility is expected.
Pessimistic target level: 0.79
Optimistic target level: 0.99
Target values for the price of one Altamira Therapeutics share for Nov 2024.
In Nov, the Negative dynamics for Altamira Therapeutics Ltd. shares will prevail with possible monthly volatility of 9.108% volatility is expected.
Pessimistic target level: 0.86
Optimistic target level: 0.95
Target values for the price of one Altamira Therapeutics share for Dec 2024.
In Dec, the Positive dynamics for Altamira Therapeutics Ltd. shares will prevail with possible monthly volatility of 17.414% volatility is expected.
Pessimistic target level: 0.90
Optimistic target level: 1.09
Altamira Therapeutics (CYTO) stock dividend
Altamira Therapeutics last paid dividends on 01/01/1970. The next scheduled payment will be on 05/01/2019. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
